ArticleMolecular therapy. Oncology2025
Development of multivalent CAR T cells as dual immunotherapy and conditioning agents.
Quenton Rashawn Bubb et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it